E2F1 antibody [16G7]
GTX70163
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityHuman, Mouse
TargetE2F1
Overview
- SupplierGeneTex
- Product NameE2F1 antibody [16G7]
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID16G7
- Concentration1.86 mg/ml
- ConjugateUnconjugated
- Gene ID1869
- Target nameE2F1
- Target descriptionE2F transcription factor 1
- Target synonymsE2F-1, RBAP1, RBBP3, RBP3, transcription factor E2F1, PBR3, PRB-binding protein E2F-1, RBAP-1, RBBP-3, retinoblastoma-associated protein 1, retinoblastoma-binding protein 3, retinoblastoma-binding protein 3 (E2F-like)
- HostMouse
- IsotypeIgG1
- Protein IDQ01094
- Protein NameTranscription factor E2F1
- Scientific DescriptionThe protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis. [provided by RefSeq, Jul 2008]
- ReactivityHuman, Mouse
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Wang LT, Liu KY, Chiou SS, et al. Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance. Cancer Lett. 2021,520:160-171. doi: 10.1016/j.canlet.2021.07.011Read this paper
- Chen HL, Gong JY, Lin SC, et al. Effects of Sclareol Against Small Cell Lung Carcinoma and the Related Mechanism: In Vitro and In Vivo Studies. Anticancer Res. 2020,40(9):4947-4960. doi: 10.21873/anticanres.14498Read this paper
- Zhong WB, Tsai YC, Chin LH, et al. A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model. Int J Mol Sci. 2018,19(7). doi: 10.3390/ijms19071834Read this paper




![WB analysis of MCF7 untreated (lane 1) or treated with 10microM etoposide for 16 hrs (lane 2 and 3) using GTX00679 E2F1 (phospho Ser364) antibody [#2]. Lane 1 and 2 : IP with pantropic anti-E2F1 antibody followed by WB with GTX00679 Lane 3 : Cell lysate analyzed by WB with GTX00679](https://www.genetex.com/upload/website/prouct_img/normal/GTX00679/GTX00679_20191104_WB_w_23053121_640.webp)
![ICC/IF analysis of 4% PFA-fixed HeLa cells using GTX66839 E2F1 antibody [4G8]. Blue : DAPI Dilution : 1:100](https://www.genetex.com/upload/website/prouct_img/normal/GTX66839/GTX66839_20190305_ICCIF_w_23061221_558.webp)